Cells Lacking the <i>RB1</i> Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival

Matthew G. Oser(Harvard University), William G. Kaelin(Broad Institute), David Pellman(Broad Institute), Colm J. Ryan(University College Dublin), Kim Maratea(AstraZeneca (United States)), Scott T. Younger(Children's Mercy Hospital), Simon T. Barry(AstraZeneca (Singapore)), Abhishek A. Chakraborty(Cleveland Clinic), Sabina Signoretti(Brigham and Women's Hospital), Elizabeth Buss(Howard Hughes Medical Institute), Alexander Spektor(Brigham and Women's Hospital), Aditi Gulati(Institute of Cancer Research), Rebecca B. Jennings(IHS Markit (United States)), Jon Travers(AstraZeneca (United Kingdom)), Glenn S. Cowley(Broad Institute), Jesse Novak(Brigham and Women's Hospital), Stefano Cairo, Abdallah Flaifel(Brigham and Women's Hospital), Laura Brullé-Soumaré(Genopole (France)), Dennis M. Bonal(Dana-Farber Cancer Institute), Paula Taylor(AstraZeneca (United Kingdom)), David E. Root(Broad Institute), Christopher J. Lord(Institute of Cancer Research), Raquel Fonseca(Dana-Farber Brigham Cancer Center), Quang-Dé Nguyen(Dana-Farber Cancer Institute), Susan Ashton(AstraZeneca (United Kingdom)), Rachel Brough(Institute of Cancer Research), Elizabeth J. Pease(AstraZeneca (United Kingdom)), Samuel K. McBrayer(The University of Texas Southwestern Medical Center)
Cancer Discovery
October 29, 2018
Cited by 178


Related Papers